UNSPSC 51162336: Aspirin/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162336 Aspirin/pseudoephedrine is a Commodity code that in recent state and local procurement activity encompasses naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers to government health and social-service facilities. State and local governments use this code to procure pharmaceutical products—both branded and generic formulations—for community health initiatives, emergency response programs, and routine healthcare delivery across state departments, counties, and cooperative purchasing alliances. The work ranges from direct purchase of specific pharmaceutical units (such as naloxone kits for opioid overdose response) to manufacturer supply agreements providing comprehensive product catalogs with detailed National Drug Codes, packaging specifications, and pricing flexibility across multiple distribution channels.

Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represent recent issuing bodies under the code. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and a two-year term with one-year renewal option. MMCAP issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026; awarded vendors will supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencara, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), with resulting agreements effective July 1, 2026. Both solicitations require vendors to demonstrate compliance with cGMP, Drug Supply Chain Security Act requirements, and specific insurance coverage thresholds.